Kohjin Bio , Ltd. Return on Equity

Kohjin Bio , Ltd. (177A.T) currently reports a ROE of 2.16%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Kohjin Bio , Ltd.'s ROE history and peer comparisons.

Kohjin Bio , Ltd.'s ROE of 2.16% is higher than the Healthcare sector average of -75.84%. That is roughly 102.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Kohjin Bio , Ltd.'s current 2.16% should be judged against Healthcare norms (sector average: -75.84%) and against 177A.T's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 2.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Kohjin Bio , Ltd., and consider following 177A.T for alerts when major investors trade the stock.

Kohjin Bio , Ltd. is classified in the Healthcare sector. On ROE, it currently shows 2.16% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 177A.T with unrelated industries.